BSE filing, NSE: SHYAMCENT. Summary written from the filing by ALFA Finder's alert engine.
Shyam Century Ferrous Ltd: key numbers
- Share price
- ₹4.64
- Market cap
- ₹98.45 Cr
- Revenue (annual)
- ₹22.40 Cr
- Net profit (annual)
- ₹-9.17 Cr
- P/E (TTM)
- -16.6×Sector 16.9×
- Promoter holding
- 49.80%+0.15% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shyam Century Ferrous Ltd
All →Shyam Century Ferrous Board Meeting Date
Shyam Century Ferrous intimated a board meeting on 05 Nov 2026 to consider unaudited Q2 and half-year results ended 30 Sep 2026. The trading window stays closed until 08 Nov 2026.
Shyam Century Ferrous Other Announcement
Shyam Century Ferrous Limited has re-appointed M/s. D. K. Chhajer & Co. as Statutory Auditors for a five-year term at its 15th Annual General Meeting.
Shyam Century Ferrous Annual General Meeting
Shyam Century Ferrous Limited held its 15th Annual General Meeting on September 25, 2026, transacting ordinary business, including the adoption of financial statements and auditor reappointment.
Shyam Century Ferrous Other Announcement
Shyam Century Ferrous Limited is sending letters to shareholders providing the access web-link for its FY 2025-26 Annual Report and 15th AGM notice.
Shyam Century Ferrous Annual General Meeting
Shyam Century Ferrous Limited has submitted its Annual Report and notice for the 15th Annual General Meeting, scheduled for September 25, 2026.
Shyam Century Ferrous Board Meeting Outcome
Shyam Century Ferrous Limited announced the re-appointment of its Statutory and Internal Auditors. These decisions were formalised during the company's board meeting on August 6, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.